---
title: "Model-guided placement of decentralized diagnostics to limit spatial spread of the 2026 Bundibugyo"
id: "medrxiv-2-model-guided-placement-of-decentralized-diagnostics-for-spatial-control-of-the"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-model-guided-placement-of-decentralized-diagnostics-for-spatial-control-of-the"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1?rss=1"
published_at: "2026-10-05T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Model-guided placement of decentralized diagnostics to limit spatial spread of the 2026 Bundibugyo
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-model-guided-placement-of-decentralized-diagnostics-for-spatial-control-of-the
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1?rss=1)
- **Published At:** 2026-10-05T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The 2026 Bundibugyo virus (BDBV) epidemic in eastern Democratic Republic of the Congo was spatially dispersed, in part because of delayed recognition and multi-day sample transport. - Authors fitted a Bayesian spatial branching-process model to public situation reports through 2 August 2026, incorporating Flowminder movement data and a latent-burden anchor. - The model included overdispersed lineage offspring, access to and turnaround for **PCR** testing, clinical recognition, isolation, contact tracing, safe burial, and behavior change. - Model scenarios replayed 2,000 posterior outbreak trees varying decentralized **PCR** laboratory counts (5–100), deployment delays (0–180 days), and postmortem rapid diagnostic test (**RDT**) coverage. - The posterior ensemble reproduced observed cases, deaths, latent burden, and spatial targets from the epidemic history. - Speed of laboratory deployment was the dominant determinant: 35 decentralized **PCR** labs averted a median 49% of future deaths if deployed immediately, 38% with 14-day delay, and 11% with 60-day delay (90% prediction intervals reported in the source). - Spatial placement also mattered: with a 30-day deployment delay, model-informed placement averted 18–33% of future deaths with 20–100 labs versus 1–8% under random placement. - Postmortem **RDTs** complemented live-case detection, increasing deaths averted (example: from 26% to 41% with 20 labs, a 14-day delay, and 75% coverage). - Authors conclude decentralized diagnostics can act as a spatial fence to slow importation-driven spread if placed ahead of likely importations and paired with staffing, isolation, tracing, and safe-burial capacity. - Source code for simulations is publicly available at the linked GitHub repository; ethical and competing-interest statements were declared in the source.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=SjXRu0wTmesLPda4SyDtpddvjtgXPNHIRc2robzr3YY-1791243664.7590976-1.2.1.1-CuWhSOr8C9iir7Px4ID7uhkP.LX_f3upQ2.ZfQF_GnCiq9t_L9MEBuWd_hWL0lZL) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Model-guided placement of decentralized diagnostics for spatial control of the 2026 Bundibugyo Ebola epidemic [ View ORCID Profile](http://orcid.org/0000-0003-0437-7916)Daniel J Klein, [ View ORCID Profile](http://orcid.org/0000-0002-2319-5010)Kyra H Grantz, [ View ORCID Profile](http://orcid.org/0000-0002-8386-5899)Caroline O Buckee, [ View ORCID Profile](http://orcid.org/0000-0002-1943-5309)Dylan B George, [ View ORCID Profile](http://orcid.org/0000-0002-3878-5056)Scott F Dowell doi: https://doi.org/10.64898/2026.09.29.26364338 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Daniel J Klein Gates Foundation * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Daniel%2BJ%2BKlein%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Klein%20DJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADaniel%2BJ%2BKlein%2B) * [ORCID record for Daniel J Klein](http://orcid.org/0000-0003-0437-7916 "Open in new tab") * For correspondence: djklein@gmail.com Kyra H Grantz Gates Foundation * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kyra%2BH%2BGrantz%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Grantz%20KH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKyra%2BH%2BGrantz%2B) * [ORCID record for Kyra H Grantz](http://orcid.org/0000-0002-2319-5010 "Open in new tab") Caroline O Buckee Gates Foundation * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Caroline%2BO%2BBuckee%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Buckee%20CO&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ACaroline%2BO%2BBuckee%2B) * [ORCID record for Caroline O Buckee](http://orcid.org/0000-0002-8386-5899 "Open in new tab") Dylan B George Gates Foundation * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dylan%2BB%2BGeorge%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=George%20DB&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADylan%2BB%2BGeorge%2B) * [ORCID record for Dylan B George](http://orcid.org/0000-0002-1943-5309 "Open in new tab") Scott F Dowell Gates Foundation * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Scott%2BF%2BDowell%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dowell%20SF&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AScott%2BF%2BDowell%2B) * [ORCID record for Scott F Dowell](http://orcid.org/0000-0002-3878-5056 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1314070/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1314070/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1314070/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1314070/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1314070/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Before 2026, Bundibugyo virus disease had only two recognized outbreaks. By August 2026, delayed recognition and multi-day sample transport in eastern Democratic Republic of the Congo had contributed to a large, spatially dispersed epidemic. We hypothesized that model-guided placement of decentralized diagnostics in frontier health zones could help contain spatial spread by acting as a spatial fence: delayed recognition would be converted into timely polymerase chain reaction (PCR) confirmation, isolation, and contact tracing before imported lineages became established. We fit a Bayesian spatial branching process to public situation reports through 2 August 2026, with Flowminder movement and a latent-burden anchor. Lineages had overdispersed offspring, PCR access and turnaround, clinical recognition, isolation, tracing, safe burial, and local behaviour change. Because the observed history did not identify future control, we assumed a national response ramp yielding West-Africa-scale status-quo burden and replayed 2,000 posterior trees with 5-100 zone-level PCR laboratories, deployment delays of 0-180 days, and postmortem rapid diagnostic test (RDT) coverage. The posterior reproduced case, death, latent-burden, and spatial targets. Speed dominated: 35 PCR laboratories averted a median 49% of future deaths if deployed immediately, 38% after 14 days, and 11% after 60 days, with 90% prediction intervals of 30-65%, 23-53%, and 5-20%, respectively. Placement also mattered: with a 30-day delay, model-informed placement averted 18-33% of future deaths with 20-100 laboratories, versus 1-8% under random placement. Postmortem RDTs partly filled gaps left by live-case detection, increasing future deaths averted from 26% to 41% with 20 laboratories, a 14-day delay, and 75% coverage. Decentralized diagnostics can slow spatial spread when they are placed ahead of likely importations and paired with staffing, isolation, tracing, and safe-burial capacity. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability This paper contains simulation-based disease modeling of the BDBV outbreak. Source code is available online. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1 "Explainable machine learning identifies predictors for postural instability and cognitive impairment in early Parkinsons Disease")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.29.26364309v1 "Estimating Hepatitis C Virus Prevalence in US States and the District of Columbia, 2017-2020") Posted October 05, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/05/2026.09.29.26364338.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.29.26364338v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/05/2026.09.29.26364338.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Model-guided placement of decentralized diagnostics for spatial control of the 2026 Bundibugyo Ebola epidemic Daniel J Klein, Kyra H Grantz, Caroline O Buckee, Dylan B George, Scott F Dowell medRxiv 2026.09.29.26364338; doi: https://doi.org/10.64898/2026.09.29.26364338 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364338v1%26text%3DModel-guided%2520placement%2520of%2520decentralized%2520diagnostics%2520for%2520spatial%2520control%2520of%2520the%25202026%2520Bundibugyo%2520Ebola%2520epidemic "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364338v1%26t%3DModel-guided%2520placement%2520of%2520decentralized%2520diagnostics%2520for%2520spatial%2520control%2520of%2520the%25202026%2520Bundibugyo%2520Ebola%2520epidemic "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364338v1%26title%3DModel-guided%2520placement%2520of%2520decentralized%2520diagnostics%2520for%2520spatial%2520control%2520of%2520the%25202026%2520Bundibugyo%2520Ebola%2520epidemic%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364338v1%26title%3DModel-guided%2520placement%2520of%2520decentralized%2520diagnostics%2520for%2520spatial%2520control%2520of%2520the%25202026%2520Bundibugyo%2520Ebola%2520epidemic "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.29.26364338) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.29.26364338v1&count=horizontal&via=&text=Model-guided%20placement%20of%20decentralized%20diagnostics%20for%20spatial%20control%20of%20the%202026%20Bundibugyo%20Ebola%20epidemic&counturl=www.medrxiv.org/content/10.64898/2026.09.29.26364338v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (626) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (340) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4885) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (486) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (421) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (659) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1643) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16063) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (34) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1218) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7128) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (736) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1072) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5122) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1447) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1792) * [Hematology](https://www.medrxiv.org/collection/hematology) (590) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1355) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16357) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1184) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (678) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (729) * [Neurology](https://www.medrxiv.org/collection/neurology) (7385) * [Nursing](https://www.medrxiv.org/collection/nursing) (370) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1102) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1263) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1010) * [Oncology](https://www.medrxiv.org/collection/oncology) (3656) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1066) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (399) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (459) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (483) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (142) * [Pathology](https://www.medrxiv.org/collection/pathology) (711) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1822) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (741) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (776) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5986) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9833) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2464) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1479) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1256) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (651) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (786) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (588) * [Surgery](https://www.medrxiv.org/collection/surgery) (786) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (310) * [Urology](https://www.medrxiv.org/collection/urology) (298) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this a
## Related Clinical Research

- [GSK wins approval for hepatitis B therapy as biotech news ripples through sector](https://medichelpline.com/clinical-feed/stat-news-0-stat-gsk-picks-up-hep-b-drug-approval.md)
- [Immune checkpoint inhibitor–related multi-organ injury with severe pneumonia: case report (Frontie](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-immune-checkpoint-inhibitor-induced-multi-organ-immune-damage-complicated-by.md)
- [Monocyte phenotypes associated with peri‑coronary inflammation in people with and without HIV](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-distinct-monocyte-phenotypes-are-associated-with-peri-coronary-inflammation-in.md)
- [Reflecting on 50 Years of Interleukin-2: Advancements in Immunotherapy and Retrovirology](https://medichelpline.com/clinical-feed/stat-news-2-opinion-50-years-ago-my-colleagues-and-i-pursued-basic-research-science-that.md)
- [State-Level Estimates of Hepatitis C Virus Prevalence in the US, 2017–2020](https://medichelpline.com/clinical-feed/medrxiv-1-estimating-hepatitis-c-virus-prevalence-in-us-states-and-the-district-of.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.